tirzepatide banned by fda Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP-1 compounding while @martymakary is photographed holding bootleg # The U.S. Food and Drug

These changes are usually not as strong as the effects of statins, but they can still be helpfulespecially for people who are overweight or have type 2 diabetes

H.GrayE

Table 1 Emerging therapeutic agents for moderate to severe ulcerative colitis: classification, mechanisms, and clinical trial status

2 Why GLP-2 Matters Promotes intestinal growth Reduces inflammation Supports intestinal repair and regeneration Potential applications across GI and rare diseases Currently in global Phase II development for Short Bowel Syndrome (SBS) Unlike GLP-1 therapies that focus on metabolic regulation, GLP-2 targets intestinal health and nutrient absorption, addressing significant unmet needs in gastrointestinal disorders